NCT05993702 2023-08-15
TAS-102 in Combination With Regorafenib or Fruquintinib for Third-line and Above Advanced Colorectal Cancer
China Medical University, China
Unknown
Clinical Trials
3 trialsNCT05635149 2022-12-02
Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Unknown
NCT04431791 2020-06-16
Real World Study of Regorafenib Versus Fruquintinib in Colorectal Cancer
Peking University
Unknown